Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIa Study of SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer Patients

NCT03066947 is registered in ClinicalTrials.gov with BriaCell Therapeutics Corporation as lead sponsor.

NCT NCT03066947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03066947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIa Study of SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer Patients
Lead sponsor
BriaCell Therapeutics Corporation
Phase
Phase 1/2
Overall status
Completed
Start date
May 5, 2017
Completion date
November 22, 2018
Enrollment
24 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm, breastcancer